Exploiting Molecular Genetic Diagnoses of Polycystic Ovary Syndrome to Achieve Better Patient Outcome

This study focused on improving the genetic diagnosis of polycystic ovary syndrome (PCOS) by using exome sequencing to identify causal mutations in related individuals with clinically defined PCOS. The research aimed to enhance understanding of PCOS's genetic components, which could lead to better patient outcomes and targeted therapies. A functional study was conducted on the growth differentiation factor-9 (GDF9) due to its role in fertility and its proximity to a PCOS-linked variant. However, the functional characterization of a GDF9 mutation was unsuccessful due to issues with overexpression of the mutant construct. Despite this, the study successfully identified putative mutations shared among first-degree relatives with PCOS, potentially aiding in understanding the disorder's aetiology.